Naturally occurring protease inhibitor resistance mutations and their frequencies in HIV proviral sequences of drug-naïve sex workers in Nairobi, Kenya

被引:0
|
作者
Raghavan Sampathkumar
Elnaz Shadabi
David La
John Ho
Binhua Liang
Joshua Kimani
Terry B Ball
Francis A Plummer
Ma Luo
机构
[1] University of Manitoba,Department of Medical Microbiology
[2] University of Nairobi,Department of Medical Microbiology
[3] Public Health Agency of Canada,National Microbiology Laboratory
关键词
Resistance Mutation; Indinavir; Nelfinavir; Lopinavir; Drug Resistance Mutation;
D O I
10.1186/1742-4690-11-S1-P133
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 6 条
  • [1] The frequencies of naturally occurring protease inhibitor resistance mutations in HIV proviral sequences of drug naïve sex workers in Nairobi, Kenya and their correlation with host immune response driven positively selected mutations in HIV-1
    Raghavan Sampathkumar
    Elnaz Shadabi
    David La
    John Ho
    Binhua Liang
    Joshua Kimani
    Francis A Plummer
    Ma Luo
    BMC Infectious Diseases, 14 (Suppl 3)
  • [2] HIV-1 drug resistance-associated mutations among HIV-1 infected drug-naïve antenatal clinic attendees in rural Kenya
    Michael Kiptoo
    James Brooks
    Raphael W Lihana
    Paul Sandstrom
    Zipporah Ng’ang’a
    Joyceline Kinyua
    Nancy Lagat
    Fredrick Okoth
    Elijah M Songok
    BMC Infectious Diseases, 13
  • [3] Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania
    Nyombi B.M.
    Holm-Hansen C.
    Kristiansen K.I.
    Bjune G.
    Müller F.
    AIDS Research and Therapy, 5 (1)
  • [4] NATURALLY OCCURRING DRUG RESISTANCE MUTATIONS IN THE HEPATITIS C VIRUS NS3 PROTEASE IN HIV/HCV COINFECTED PATIENTS TREATED WITH HIV PROTEASE INHIBITORS
    Bottecchia, M.
    Madejon, A.
    Sanchez-Carillo, M.
    Labarga, P.
    Garcia-Samaniego, J.
    Soriano, V.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S289 - S289
  • [5] Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
    Angela Costantino
    Enea Spada
    Michele Equestre
    Roberto Bruni
    Elena Tritarelli
    Nicola Coppola
    Caterina Sagnelli
    Evangelista Sagnelli
    Anna Rita Ciccaglione
    Virology Journal, 12
  • [6] A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial
    Collins C. Iwuji
    Duncan Churchill
    Stephen Bremner
    Nicky Perry
    Ye To
    Debbie Lambert
    Chloe Bruce
    Laura Waters
    Chloe Orkin
    Anna Maria Geretti
    BMC Infectious Diseases, 20